These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34092607)

  • 41. Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
    Mulé S; Chalaye J; Legou F; Tenenhaus A; Calderaro J; Galletto Pregliasco A; Laurent A; Kharrat R; Amaddeo G; Regnault H; Tacher V; Kobeiter H; Itti E; Luciani A
    Eur Radiol; 2020 Oct; 30(10):5348-5357. PubMed ID: 32405753
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors.
    Li SH; Wei W; Guo RP; Shi M; Guo ZX; Chen ZY; Xiao CZ; Cai MY; Zheng L
    Med Oncol; 2013 Dec; 30(4):696. PubMed ID: 23975633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term survival in patients with T2 hepatocellular carcinoma after primary curative resection can be further stratified by tumor size.
    Ho CM; Hu RH; Lee PH; Wu YM; Ho MC
    Medicine (Baltimore); 2014 Dec; 93(27):e203. PubMed ID: 25501076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of virtual biopsy to the screening of microvascular invasion in hepatocellular carcinoma: A pilot study.
    Poté N; Cauchy F; Albuquerque M; Cros J; Soubrane O; Bedossa P; Paradis V
    Liver Int; 2018 Apr; 38(4):687-694. PubMed ID: 28872754
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.
    He YZ; He K; Huang RQ; Wang ZL; Ye SW; Liu LW; Luo QJ; Hu ZM
    Ann Hepatol; 2020; 19(6):654-661. PubMed ID: 32768591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
    Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
    BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IVIM improves preoperative assessment of microvascular invasion in HCC.
    Wei Y; Huang Z; Tang H; Deng L; Yuan Y; Li J; Wu D; Wei X; Song B
    Eur Radiol; 2019 Oct; 29(10):5403-5414. PubMed ID: 30877465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High preoparative levels of serum periostin are associated with poor prognosis in patients with hepatocellular carcinoma after hepatectomy.
    Lv Y; Wang W; Jia WD; Sun QK; Huang M; Zhou HC; Xia HH; Liu WB; Chen H; Sun SN; Xu GL
    Eur J Surg Oncol; 2013 Oct; 39(10):1129-35. PubMed ID: 23916473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New scoring system for prediction of microvascular invasion in patients with hepatocellular carcinoma.
    Shirabe K; Toshima T; Kimura K; Yamashita Y; Ikeda T; Ikegami T; Yoshizumi T; Abe K; Aishima S; Maehara Y
    Liver Int; 2014 Jul; 34(6):937-41. PubMed ID: 24393295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma.
    Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY
    Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictors of microvascular invasion before hepatectomy for hepatocellular carcinoma.
    Kaibori M; Ishizaki M; Matsui K; Kwon AH
    J Surg Oncol; 2010 Oct; 102(5):462-8. PubMed ID: 20872949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. When to call it off: defining transplant candidacy limits in liver donor liver transplantation for hepatocellular carcinoma.
    Bhatti ABH; Qureshi AI; Tahir R; Dar FS; Khan NY; Zia HH; Riyaz S; Rana A
    BMC Cancer; 2020 Aug; 20(1):754. PubMed ID: 32787864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bioinformatics Analysis of Prognostic Tumor Microenvironment-Related Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Tian Z; Wang Z; Chen Y; Qu S; Liu C; Chen F; Ma L; Zhu J
    Med Sci Monit; 2020 Mar; 26():e922159. PubMed ID: 32231177
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma.
    Li M; Luo RZ; Chen JW; Cao Y; Lu JB; He JH; Wu QL; Cai MY
    J Transl Med; 2011 Jan; 9():5. PubMed ID: 21205329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Utility of Protein Induced by Vitamin K Absence-II in Patients with Hepatocellular Carcinoma.
    Bhatti ABHH; Naz K; Abbas G; Khan NY; Zia HH; Ahmed IN
    Asian Pac J Cancer Prev; 2021 Jun; 22(6):1731-1736. PubMed ID: 34181327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma.
    Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z
    Front Immunol; 2021; 12():653836. PubMed ID: 33897701
    [No Abstract]   [Full Text] [Related]  

  • 57. Infiltrative Hepatocellular Carcinoma: Assessment of Factors Associated With Outcomes in Patients Undergoing Hepatectomy.
    Yan X; Fu X; Deng M; Chen J; He J; Shi J; Qiu Y
    Medicine (Baltimore); 2016 May; 95(19):e3589. PubMed ID: 27175659
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The significance of classifying microvascular invasion in patients with hepatocellular carcinoma.
    Sumie S; Nakashima O; Okuda K; Kuromatsu R; Kawaguchi A; Nakano M; Satani M; Yamada S; Okamura S; Hori M; Kakuma T; Torimura T; Sata M
    Ann Surg Oncol; 2014 Mar; 21(3):1002-9. PubMed ID: 24254204
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combined AFP-CRUT with microvascular invasion accurately predicts mortality risk in patients with hepatocellular carcinoma following curative liver resection.
    Huang GQ; Zhu GQ; Huang S; You J; Shi KQ; Hu B; Ruan LY; Zhou MT; Braddock M; Zheng MH
    Expert Rev Gastroenterol Hepatol; 2015; 9(8):1127-38. PubMed ID: 26186642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.